November 17, 2025 Quanterix Announces Landmark Study Demonstrating Dual GFAP/NfL Blood Test Approach for Personalized Multiple Sclerosis Monitoring
August 21, 2025 Quanterix Accelerator Laboratory Awarded Rigorous New York State Clinical Laboratory Permit